IDNA News and Press, iShares Genomics Immunology and Healthcare From 08/29/23

2023-08-29 03:25:00 ET Summary Investing is a lot like long-distance running; sometimes the hardest part is just getting started. Exchange Traded Funds (ETFs) can be a great option for beginning investors as they can help you create a diversified portfolio and alleviate the challe...

2023-08-16 02:28:00 ET Summary Risk-on sentiment and end of pandemic boom have weighed on healthcare. Health insurers and medical device firms have held up better. Growing opportunity in obesity treatments. Tarik Aeta, Global Healthcare Analyst with TD Asset Mana...

2023-08-14 08:15:00 ET Summary This article provides a dashboard with industry metrics in healthcare, then focus on the Global X Genomics & Biotechnology ETF. Pharmaceuticals/biotechnology and healthcare providers have fair value and quality scores. Healthcare equipment is...

2023-08-11 01:45:00 ET Summary The U.S. healthcare system remains a global outlier in both innovation and cost. The U.S. spends twice as much per capita on healthcare versus its developed-country peers yet life expectancy is lower by 6.3 years. Healthcare companies continue to...

2023-07-25 04:17:00 ET Summary Over the last seven recessionary periods in the U.S., healthcare outperformed the broader market by an average of 10%. Slowing economies call for the resilience that healthcare companies can offer, yet the sector remains at a 10% discount to global e...

2023-07-25 01:30:00 ET Summary Why the stock market gains we're seeing may not be telling the whole story. Investors may have been too focused on market capitalization in the first half. Finding opportunities in the healthcare sector. The strong market performance ...

2023-07-24 22:24:00 ET Summary Equity and fixed income markets experienced heightened volatility amid the Q2 debt-ceiling saga, while currency and derivatives markets were mostly unaffected. Regional banks struggled in Q2, with deposits and witnessed credit spreads widening by 100...

2023-07-23 05:45:00 ET Summary Novartis has signed a $1 billion deal to acquire DTx Pharma - DTx Pharma shareholders will receive $500 million upfront and up to $500 million in milestones. Sichuan Kelun-Biotech completed a $174 million IPO on the Hong Kong Exchange, valuing the co...

2023-07-11 21:25:00 ET Summary Health care’s innovation-driven growth and inherent resilience makes it a natural fit for dividend growth investors, according to Franklin Equity Group. Technology in health care has historically driven a broad range of innovation, from the do...

2023-06-19 05:16:46 ET Summary Pharma/biotechnology and healthcare providers are slightly undervalued relative to 11-year averages. Healthcare equipment is the most overvalued subsector. Fast facts on PBE, a genomics ETF. 10 healthcare stocks cheaper than their peers in Ju...